These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A rational approach for cancer stem-like cell isolation and characterization using CD44 and prominin-1(CD133) as selection markers. Lee YJ; Wu CC; Li JW; Ou CC; Hsu SC; Tseng HH; Kao MC; Liu JY Oncotarget; 2016 Nov; 7(48):78499-78515. PubMed ID: 27655682 [TBL] [Abstract][Full Text] [Related]
4. Suitability of CD133 as a Marker for Cancer Stem Cells in Melanoma. Korn P; Kampmann A; Spalthoff S; Jehn P; Tavassol F; Lentge F; Gellrich NC; Zimmerer R Asian Pac J Cancer Prev; 2021 May; 22(5):1591-1597. PubMed ID: 34048190 [TBL] [Abstract][Full Text] [Related]
5. CD133 and CD44 cell surface markers do not identify cancer stem cells in primary human gastric tumors. Rocco A; Liguori E; Pirozzi G; Tirino V; Compare D; Franco R; Tatangelo F; Palaia R; D'Armiento FP; Pollastrone G; Affuso A; Bottazzi EC; Masone S; Persico G; Nardone G J Cell Physiol; 2012 Jun; 227(6):2686-93. PubMed ID: 21898409 [TBL] [Abstract][Full Text] [Related]
6. HERV-K activation is strictly required to sustain CD133+ melanoma cells with stemness features. Argaw-Denboba A; Balestrieri E; Serafino A; Cipriani C; Bucci I; Sorrentino R; Sciamanna I; Gambacurta A; Sinibaldi-Vallebona P; Matteucci C J Exp Clin Cancer Res; 2017 Jan; 36(1):20. PubMed ID: 28125999 [TBL] [Abstract][Full Text] [Related]
7. A distinct subpopulation within CD133 positive brain tumor cells shares characteristics with endothelial progenitor cells. Choi SA; Wang KC; Phi JH; Lee JY; Park CK; Park SH; Kim SK Cancer Lett; 2012 Nov; 324(2):221-30. PubMed ID: 22652175 [TBL] [Abstract][Full Text] [Related]
8. Phenotypic subpopulations of metastatic colon cancer stem cells: genomic analysis. Botchkina IL; Rowehl RA; Rivadeneira DE; Karpeh MS; Crawford H; Dufour A; Ju J; Wang Y; Leyfman Y; Botchkina GI Cancer Genomics Proteomics; 2009; 6(1):19-29. PubMed ID: 19451087 [TBL] [Abstract][Full Text] [Related]
9. MicroRNA-92 Expression in CD133 Shidal C; Singh NP; Nagarkatti P; Nagarkatti M Cancer Res; 2019 Jul; 79(14):3622-3635. PubMed ID: 31015227 [TBL] [Abstract][Full Text] [Related]
10. [Isolation and in vivo tumorigenicity assay of CD133+ side population cells from laryngeal cancer cell line]. Wu CP; Zhou L; Xie M; Tao L; Zhang M; Tian J Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Mar; 47(3):223-7. PubMed ID: 22805024 [TBL] [Abstract][Full Text] [Related]
11. Isolation and identification of cancer stem-like cells from murine melanoma cell lines. Dou J; Pan M; Wen P; Li Y; Tang Q; Chu L; Zhao F; Jiang C; Hu W; Hu K; Gu N Cell Mol Immunol; 2007 Dec; 4(6):467-72. PubMed ID: 18163959 [TBL] [Abstract][Full Text] [Related]
12. Do Cancer Cell Lines Have Fixed or Fluctuating Stem Cell Phenotypes? - Studies with the NTera2 Cell Line. Sellers ZP; Schneider G; Bujko K; Suszynska M; Pedziwiatr D Stem Cell Rev Rep; 2017 Oct; 13(5):603-610. PubMed ID: 28624968 [TBL] [Abstract][Full Text] [Related]
13. A possible interplay between HR-HPV and stemness in tumor development: an in vivo investigation of CD133 as a putative marker of cancer stem cell in HPV18-infected KB cell line. de Maria S; Santoro A; Fuggetta MP; Rocchetti R; Cottarelli A; Lanzilli G; Stiuso P; Angelico G; Spadola S; Franco Zannoni G; Rubini C; Emanuelli M; Carmela Pedicillo M; Pannone G; Muzio LL APMIS; 2020 Dec; 128(12):637-646. PubMed ID: 32911563 [TBL] [Abstract][Full Text] [Related]
14. Characteristics of CD133(+) human colon cancer SW620 cells. Kawamoto H; Yuasa T; Kubota Y; Seita M; Sasamoto H; Shahid JM; Hayashi T; Nakahara H; Hassan R; Iwamuro M; Kondo E; Nakaji S; Tanaka N; Kobayashi N Cell Transplant; 2010; 19(6):857-64. PubMed ID: 20587144 [TBL] [Abstract][Full Text] [Related]
16. ABCG2 is required for self-renewal and chemoresistance of CD133-positive human colorectal cancer cells. Ma L; Liu T; Jin Y; Wei J; Yang Y; Zhang H Tumour Biol; 2016 Sep; 37(9):12889-12896. PubMed ID: 27449042 [TBL] [Abstract][Full Text] [Related]
17. Melanoma contains CD133 and ABCG2 positive cells with enhanced tumourigenic potential. Monzani E; Facchetti F; Galmozzi E; Corsini E; Benetti A; Cavazzin C; Gritti A; Piccinini A; Porro D; Santinami M; Invernici G; Parati E; Alessandri G; La Porta CA Eur J Cancer; 2007 Mar; 43(5):935-46. PubMed ID: 17320377 [TBL] [Abstract][Full Text] [Related]
18. Melanoma stem cells: the dark seed of melanoma. Zabierowski SE; Herlyn M J Clin Oncol; 2008 Jun; 26(17):2890-4. PubMed ID: 18539969 [TBL] [Abstract][Full Text] [Related]
19. Bone marrow-derived mesenchymal stem cells increase drug resistance in CD133-expressing gastric cancer cells by regulating the PI3K/AKT pathway. Ji N; Yu JW; Ni XC; Wu JG; Wang SL; Jiang BJ Tumour Biol; 2016 Nov; 37(11):14637-14651. PubMed ID: 27619680 [TBL] [Abstract][Full Text] [Related]
20. Cells with characteristics of cancer stem/progenitor cells express the CD133 antigen in human endometrial tumors. Rutella S; Bonanno G; Procoli A; Mariotti A; Corallo M; Prisco MG; Eramo A; Napoletano C; Gallo D; Perillo A; Nuti M; Pierelli L; Testa U; Scambia G; Ferrandina G Clin Cancer Res; 2009 Jul; 15(13):4299-311. PubMed ID: 19509143 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]